Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02197247
Title Study to Assess the Effect of Rifampicin on Blood Levels and Safety of AZD9291, in Patients With EGFRm+ NSCLC
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | NLD | GBR | ESP

Facility Status City State Zip Country Details
Research Site Atlanta Georgia 30322 United States Details
Research Site Detroit Michigan 48202 United States Details
Research Site Seongnam-si 13620 Korea, Republic of Details
Research Site Seoul 03722 Korea, Republic of Details
Research Site Seoul 06351 Korea, Republic of Details
Research Site Amsterdam 1066 CX Netherlands Details
Research Site Maastricht 6229 HX Netherlands Details
Research Site Barcelona 08041 Spain Details
Research Site L'Hospitalet de Llobregat 08908 Spain Details
Research Site Madrid 28040 Spain Details
Research Site Madrid 28041 Spain Details
Research Site Madrid 28046 Spain Details
Research Site Málaga 29010 Spain Details
Research Site Sevilla 41013 Spain Details
Research Site Taipei 10002 Taiwan Details
Research Site Taipei 112 Taiwan Details
Research Site Cardiff CF14 2TL United Kingdom Details
Research Site Manchester M20 4BX United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field